J. Robert

发表

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

S. Paik, C. Geyer, N. Wolmark, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of Factors Associated with Recruitment in Breast Cancer Clinical Trials in a Specialized Breast Cancer Centre.

G. Forget, S. Camden, J. Robert, 2009 .

Breast cancer survivors accurately reported key treatment and prognostic characteristics.

E. Maunsell, J. Robert, M. Drolet, 2005, Journal of clinical epidemiology.

Dietary change after breast cancer: extent, predictors, and relation with psychological distress.

J. Brisson, L. Deschênes, E. Maunsell, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blood lipids and prostate cancer: a Mendelian randomization analysis PRACTICAL consortium

Ali Amin Al Olama, R. Eeles, G. Giles, 2020 .

PRACTICAL (2016). Blood lipids and prostate cancer: a Mendelian randomization analysis.

Ali Amin Al Olama, R. Eeles, G. Giles, 2016 .

Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations.

P. Ayotte, É. Dewailly, J. Brisson, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.

L. Bourget, J. Robert, Y. Fradet, 1990, Cancer research.

Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.

J. Robert, B. Poirier, C. Diorio, 2011, Breast.

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study

R. Schiff, P. Neven, J. Mackey, 2011, Clinical Cancer Research.

Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population.

F. Rousseau, P. Ayotte, É. Dewailly, 2001, Cancer research.

Quantitative exploration of possible reasons for the recent improvement in breast cancer survival

T. Duchesne, J. Brisson, N. Hébert-croteau, 2007, Breast Cancer Research and Treatment.

Tamoxifen and mammographic breast densities.

J. Brisson, E. Maunsell, J. Robert, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.

D. Tu, V. Bramwell, B. Norris, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantitative DNA methylation analysis of laser capture microdissected formalin-fixed and paraffin-embedded tissues.

J. Gagnon, F. Sanschagrin, J. Robert, 2010, Experimental and molecular pathology.

Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis.

P. Ayotte, É. Dewailly, J. Brisson, 2002, American journal of epidemiology.

Wage losses in the year after breast cancer: extent and determinants among Canadian women.

D. Coyle, A. Robidoux, S. Lauzier, 2008, Journal of the National Cancer Institute.

Conceptualization and sources of costs from breast cancer: Findings from patient and caregiver focus groups

S. Lauzier, N. Hébert-croteau, E. Maunsell, 2005, Psycho-oncology.

Psychological distress and physical health in the year after diagnosis of DCIS or invasive breast cancer

A. Robidoux, S. Lauzier, E. Maunsell, 2010, Breast Cancer Research and Treatment.

Activity and safety of the antiestrogen EM-800, the orally active precursor of acolbifene, in tamoxifen-resistant breast cancer.

J. Roy, C. Labrie, M. Pollak, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).

D. Tu, V. Bramwell, K. Pritchard, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized clinical trial on cognitive therapy for depression in women with metastatic breast cancer: Psychological and immunological effects

C. Morin, P. Gagnon, J. Savard, 2006, Palliative and Supportive Care.

Tamoxifen and Mammographic Breast Densities 1

J. Brisson, E. Maunsell, J. Robert, 2000 .

Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer.

D. Coyle, A. Robidoux, S. Lauzier, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gefitinib or Placebo in Combination with Tamoxifen in Patients with Hormone Receptor–Positive Metastatic Breast Cancer: A Randomized Phase II Study

R. Schiff, P. Neven, J. Mackey, 2011, Clinical Cancer Research.

Wage losses in the year after breast cancer: extent and determinants among Canadian women.

D. Coyle, A. Robidoux, S. Lauzier, 2008, Journal of the National Cancer Institute.